[1]徐子龙,王遥,谭炜焓,等.中医虚实辨证法辨治三阴性乳腺癌述评[J].西部中医药,2023,36(08):153-156.[doi:10.12174/j.issn.2096-9600.2023.08.37]
　XU Zilong,WANG Yao,TAN Weihan,et al.A Commentary on Differentiating and Treating Triple Negative Breast Cancer by Syndrome Differentiation of Deficiency and Excess[J].Western Journal of Traditional Chinese Medicine,2023,36(08):153-156.[doi:10.12174/j.issn.2096-9600.2023.08.37]
点击复制

中医虚实辨证法辨治三阴性乳腺癌述评
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年08期
页码:
153-156
栏目:
出版日期:
2023-08-15

文章信息/Info

Title:
A Commentary on Differentiating and Treating Triple Negative Breast Cancer by Syndrome Differentiation of Deficiency and Excess
作者:
徐子龙, 王遥, 谭炜焓, 梁丹, 李卓虹
成都中医药大学附属医院,四川 成都 610072
Author(s):
XU Zilong, WANG Yao, TAN Weihan, LIANG Dan, LI Zhuohong
Teaching Hospital of Chengdu University of TCM, Chengdu 610072, China
关键词:
三阴性; 乳腺癌; 证; 型
Keywords:
triple negative; breast cancer; pattern
分类号:
R737.9
DOI:
10.12174/j.issn.2096-9600.2023.08.37
文献标志码:
A
摘要:
归纳整理三阴性乳腺癌相关文献、期刊资料及众多学者的临床经验，分析总结三阴性乳腺癌的疾病本质、发病特点、病因病机、治疗总纲。以“虚实辨证法”为基础提出三阴性乳腺癌的中医辨证分型及其相关治疗原则，为临床治疗提供参考。
Abstract:
By summarizing and organizing the relevant literature and periodicals and clinical experience of numerous scholars, the article analyzes and concludes the nature, the onset characteristics, the cause and pathogenesis, therapeutic outlines of triple negative breast cancer. Syndrome differentiation and patterns, and the related therapeutic principles of the disease was put forward based on "syndrome differentiation of deficiency and excess", so as to provide the reference for clinical treatment.

相似文献/References:

[1]王斌,王艳杰,梁贵文,等.乳积方防治乳腺癌患者术后复发转移的临床研究*[J].西部中医药,2013,26(08):101.
　WANG Bin,WANG Yanjie,LIANG Guiwen,et al.Clinical Study on RuJiFang to Prevent Postoperative Recurrence and Metastasis of Breast Cancer[J].Western Journal of Traditional Chinese Medicine,2013,26(08):101.
[2]侯俊明,江静.疏肝解郁法联合化疗治疗乳腺癌临床疗效分析[J].西部中医药,2014,27(09):1.
[3]王丽,何丽娟,朱玉芹.循证护理对乳腺癌化疗患者自尊水平和应对方式的影响[J].西部中医药,2014,27(11):134.
[4]朱慧华.纽曼护理对乳腺癌手术患者心理健康和生活质量的影响[J].西部中医药,2014,27(12):105.
[5]张晓华,张晓岚△,梁玉荣,等.综合心理干预对乳腺癌化疗患者医学应对方式及生命质量的影响[J].西部中医药,2015,28(07):123.
[6]谷雨,华海清△.中医辨证分型与乳腺癌预后的相关性研究[J].西部中医药,2015,28(04):85.
[7]刘琛,吴黎雅,赵红佳,等.人参养荣汤干预乳腺癌新辅助化疗所致气血两虚证的临床研究[J].西部中医药,2011,24(11):3.
[8]李树建.扶正祛积汤联合CEF化疗方案治疗晚期乳腺癌40例临床研究[J].西部中医药,2013,26(09):1.
　LI Shujian.Clinical Study on FuZheng QuJiTang Combined with CEF Chemotherapy in Treating 40 Patients Suffering from Advanced Mammary Cancer[J].Western Journal of Traditional Chinese Medicine,2013,26(08):1.
[9]安妮,杨俊兰.消 疒徵祛积方联合化疗对晚期乳腺癌患者血清CEA、CA125、CA153和CA19-9含量及临床疗效的影响[J].西部中医药,2013,26(03):7.
　AN Ni,YANG Junlan.Effects of XiaoZhen QuJiFang and Chemotherapy on Clinical Efficacy and Contents of Serum CEA, CA125, CA153 and CA19-9 of Patients with Mammary Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2013,26(08):7.
[10]朱竹华,许敏菊,张汀荣,等.以家庭为中心的护理模式在完全植入式静脉输液港乳腺癌化疗患者中的应用[J].西部中医药,2016,29(03):114.
　ZHU Zhuhua,XU Minju,ZHANG Dingrong,et al.FCC Applying to Breast Cancer Patients Who Received Chemotherapy by TIVAP[J].Western Journal of Traditional Chinese Medicine,2016,29(08):114.

备注/Memo

备注/Memo:
徐子龙（1999—），男，在读硕士研究生。研究方向：泌尿及生殖系统疾病的诊治。国家自然科学基金青年基金（81804081）；成都中医药大学“杏林学者”学科人科研提升计划项目（QNXZ2019012）。
更新日期/Last Update: 2023-08-15